Latest News about ONCR
Recent news which mentions ONCR
From Benzinga
 From Benzinga
 From Benzinga
 
   79 Biggest Movers From Yesterday
   
  
  
  June 08, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  April 21, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  April 20, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  April 19, 2022
  From Benzinga
 
   18 Stocks Moving in Tuesday's Pre-Market Session
   
  
  
  April 05, 2022
  From Benzinga
 From InvestorPlace
 From Benzinga
 
   63 Biggest Movers From Yesterday
   
  
  
  March 04, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  February 18, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  February 17, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  February 14, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  February 10, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  February 07, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
   
  
  
  November 18, 2021
  From Benzinga
 
   70 Biggest Movers From Friday
   
  
  
  November 15, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
   
  
  
  November 14, 2021
  From Benzinga
 
   Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop
   
  
  
  November 12, 2021
  From Benzinga
 
   Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet
   
  
  
  November 12, 2021
  From Benzinga
 
   48 Stocks Moving In Friday's Mid-Day Session
   
  
  
  November 12, 2021
  From Benzinga
 
   Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter
   
  
  
  November 12, 2021
  From Benzinga
 
   Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement
   
  
  
  November 11, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.